Ivan Jambor

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

European Radiology

Beheshti Mohsen, Taimen Pekka, Kemppainen Jukka, Jambor Ivan, Mueller Andre, Loidl Wolfgang, Kähkönen Esa, Käkelä Meeri, Berndt Mathias, Stephens Andrew W., Minn Heikki, Langsteger Werner

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer (2022)

Cancers

Chakravarty Dimple, Ratnani Parita, Huang Li, Dovey Zachary, Sobotka Stanislaw, Berryhill Roy, Merisaari Harri, Al Shaarani Majd, Rai Richa, Jambor Ivan, Yadav Kamlesh K., Mittan Sandeep, Parekh Sneha, Kodysh Julia, Wagaskar Vinayak, Brody Rachel, Cordon-Cardo Carlos, Rykunov Dmitry, Reva Boris, Davicioni Elai, Wiklund Peter, Bhardwaj Nina, Nair Sujit S., Tewari Ashutosh K.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer (2022)

Nuclear Medicine Communications

Arvola Samuli, Seppänen Marko, Malaspina Simona, Mätzke Sorjo, Raiko Juho, Timonen Kirsi L, Ettala Otto, Jambor Ivar, Anttinen Mikael, Kuisma Anna, Löyttyniemi Eliisa, Boström Peter J, Sohlberg Antti, Noponen Tommi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level (2022)

World Journal of Urology

Falagario Ugo Giovanni, Chakravarty Dimple, Martini Alberto, Shahait Mohammed, El-Fahmawi Ayah, Jambor Ivan, Lantz Anna, Grannas David, Ratnani Parita, Parekh Sneha, Lundon Dara, Haines Kenneth, Cormio Luigi, Carrieri Giuseppe, Kyprianou Natasha, Kattan Michael W., Klein Eric A., Wiklund Peter, Lee David I., Tewari Ash

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk Score (2022)

European Urology

Peters Max, Eldred-Evans David, Kurver Piet, Falagario Ugo Giovanni, Connor Martin J., Shah Taimur T., Verhoeff Joost J.C., Taimen Pekka, Aronen Hannu J., Knaapila Juha, Montoya Perez Ileana, Ettala Otto, Stabile Armando, Gandaglia Giorgio, Fossati Nicola, Martini Alberto, Cucchiara Vito, Briganti Alberto, Lantz Anna, Picker Wolfgang, Haug Erik Skaaheim, Nordström Tobias, Tanaka Mariana Bertoncelli, Reddy Deepika, Bass Edward, van Rossum Peter S.N., Wong Kathie, Tam Henry, Winkler Mathias, Gordon Stephen, Qazi Hasan, Boström Peter J., Jambor Ivan, Ahmed Hashim U.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Whole Brain Adiabatic T-1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings (2021)

Journal of Magnetic Resonance Imaging

Jambor Ivan, Steiner Aida, Pesola Marko, Liimatainen Timo, Sucksdorff Marcus, Rissanen Eero, Airas Laura, Aronen Hannu J, Merisaari Harri

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study (2021)

npj Precision Oncology

Leo Patrick, Janowczyk Andrew, Elliott Robin, Janaki Nafiseh, Bera Kaustav, Shiradkar Rakesh, Farré Xavier, Fu Pingfu, El-Fahmawi Ayah, Shahait Mohammed, Kim Jessica, Lee David, Yamoah Kosj, Rebbeck Timothy R., Khani Francesca, Robinson Brian D., Eklund Lauri, Jambor Ivan, Merisaari Harri, Ettala Otto, Taimen Pekka, Aronen Hannu J., Boström Peter J., Tewari Ashutosh, Magi-Galluzzi Cristina, Klein Eric, Purysko Andrei, Shih Natalie NC, Feldman Michael, Gupta Sanjay, Lal Priti, Madabhushi Anant

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies (2021)

European Urology Focus

Juha Knaapila, Ivan Jambor, Otto Ettala, Pekka Taimen, Janne Verho, Ileana Montoya Perez, Aida Kiviniemi, Tapio Pahikkala, Harri Merisaari, Tarja Lamminen, Jani Saunavaara, Hannu J.Aronen, Kari T.Syvänen, Peter J.Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

European Radiology

Hiremath Amogh, Shiradkar Rakesh, Merisaari Harri, Prasanna Prateek, Ettala Otto, Taimen Pekka, Aronen Hannu J, Boström Peter J, Jambor Ivan, Madabhushi Anant

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)

International Journal of Radiation Oncology - Biology - Physics

Dai Z, Jambor I, Taimen P, Pantelic M, Elshaikh MA, Dabaja A, Rogers C, Ettala O, Bostrom P, Aronen H, Merisaari H, Wen N

(O2 Muu julkaisu )

Contact

Publications

Sort by:

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer (2022)

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer (2022)

When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level (2022)

Whole Brain Adiabatic T-1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings (2021)

Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study (2021)

Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies (2021)

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)